Polyethylene glycol 3350 plus electrolytes for chronic constipation in children: A double blind, placebo controlled, crossover study

Archives of Disease in Childhood

Volumn 92, Issue 11, 2007, Pages 996-1000

  Thomson, M A ^a   Jenkins, H R ^b   Bisset, W M ^c   Heuschkel, R ^d   Kalra, D S ^e   Green, M R ^f   Wilson, D C ^g,h   Geraint, M ⁱ  

^a SHEFFIELD CHILDREN S HOSPITAL   (United Kingdom)

^b UNIVERSITY HOSPITAL OF WALES   (United Kingdom)

^c ROYAL ABERDEEN CHILDREN S HOSPITAL   (United Kingdom)

^d ROYAL FREE HOSPITAL   (United Kingdom)

^e NEW CROSS HOSPITAL   (United Kingdom)

^f LEICESTER ROYAL INFIRMARY   (United Kingdom)

^g ROYAL HOSPITAL FOR SICK CHILDREN   (United Kingdom)

^h UNIVERSITY OF EDINBURGH   (United Kingdom)

ⁱ Norgine Ltd   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ELECTROLYTE; LAXATIVE; MACROGOL 3350; MOVICO; PLACEBO; UNCLASSIFIED DRUG;

ABDOMINAL PAIN; ARTICLE; CHILD; CHRONIC DISEASE; CLINICAL TRIAL; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DEFECATION; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; FECES INCONTINENCE; FEMALE; GASTROINTESTINAL SYMPTOM; HUMAN; INFANT; MALE; PAINFUL DEFECATION; PHYSICAL EXAMINATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; UNITED KINGDOM;

CATHARTICS; CHILD; CHILD, PRESCHOOL; CHRONIC DISEASE; CONSTIPATION; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; ELECTROLYTES; FEMALE; HUMANS; MALE; POLYETHYLENE GLYCOLS; TREATMENT OUTCOME;

EID: 35748956089     PISSN: 00039888     EISSN: 14682044     Source Type: Journal    
DOI: 10.1136/adc.2006.115493     Document Type: Article

References (11)

1. Candy D, Davies G, Ross R, eds. Clinical paediatrics and child health, Edinburgh: WB Saunders, 2001.
2. Loening-Baucke V. Chronic constipation in children. Gastroenterology 1993;105:1557-64.
3. Fitzgerald JF. Constipation in children. Pediatr Rev 1987;8:299-302.
4. Price KJ, Elliott TM. What is the role of stimulant laxatives in the management of childhood constipation and soiling? Cochrane Database Syst Rev 2001;(3):CD002040.
5. Culbert P, Gillet H, Ferguson A. Highly effective oral therapy (polyethylene glycol/electrolyte solution) for faecal impaction and severe constipation. Clin Drug Invest 1998;16(5):153-5.
6. Vincent R, Candy DCA. Movicol for the treatment of faecal impaction in children. Gastroenterology 2001;11(2): 1-4.
7. Loening-Baucke V. Polyethylene glycol without electrolytes for children with constipation and encopresis. J Pediatr Castroenterol Nutr 2002;34:372-7.
8. Pashankar DS, Bishop WP. Efficacy and optimal dose of daily polyethylene glycol 3350 for treatment of constipation and encopresis in children. J Pediatr 2001;139:428-32.
9. Pashankar DS, Loening-Baucke V, Bishop WP. Safety of polyethylene glycol 3350 for the treatment of constipation in children. Arch Pediatr Adolesc Med 2003;157:661-4.
10. Voskuijl W, de Lorijn F, Verijs W, et al. PEG 3350 (Transipeg) versus lactulose in the treatment of childhood functional constipation: a double blind, randomised, controlled, multicentre trial. Gut 2004;53:1590-4.
11. Mason D, Tobias N, Lutkenhoff M, et al. The APN's guide to pediatric constipation management. Nurse Pract 2004;29:13-21.